Thesis
Nutraceuticals
8 open rolesNutraceuticalsNew York City, United States24 employees$14M raisedEst. 2017
About Thesis
- Thesis offers customized nootropics that target key neurotransmitters and hormones to support cognitive function, focus, learning, motivation, memory, and stress resilience.
- It is described as the world's first personalized brain supplement brand.
Thesis is listed on Rocketlist with 8 active roles. The company is categorized as Nutraceuticals in HealthTech. Thesis is at Series A stage, with a B2C business model, headquartered in New York City, United States. Thesis was founded in 2017 and has 24 employees. Thesis has raised $14M. Active roles are refreshed daily from public hiring sources.